The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Levothyroxine sodium Aristo 125 micrograms tablets



Aristo Pharma GmbHPA1983/004/006

Main Information

Trade NameLevothyroxine sodium Aristo 125 micrograms tablets
Active SubstancesLevothyroxine Sodium Anhydrous EP
Dosage FormTablet
Licence HolderAristo Pharma GmbH
Licence NumberPA1983/004/006

Group Information

ATC CodeH03AA01 levothyroxine sodium

Status

License statusAuthorised
Licence Issued12/08/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back